FALZARANO, Maria Sofia
 Distribuzione geografica
Continente #
NA - Nord America 7.893
AS - Asia 3.942
EU - Europa 3.203
SA - Sud America 699
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 94
OC - Oceania 61
Totale 16.036
Nazione #
US - Stati Uniti d'America 7.627
SG - Singapore 1.474
CN - Cina 953
PL - Polonia 768
IT - Italia 745
BR - Brasile 557
VN - Vietnam 432
DE - Germania 428
HK - Hong Kong 308
UA - Ucraina 268
GB - Regno Unito 261
TR - Turchia 203
CA - Canada 139
FR - Francia 129
FI - Finlandia 127
SE - Svezia 126
BD - Bangladesh 112
JP - Giappone 109
RU - Federazione Russa 104
IN - India 103
MX - Messico 83
ID - Indonesia 63
NL - Olanda 56
AR - Argentina 55
AU - Australia 46
BE - Belgio 40
ES - Italia 40
ZA - Sudafrica 40
PK - Pakistan 31
IQ - Iraq 30
CO - Colombia 24
CZ - Repubblica Ceca 19
LT - Lituania 17
MA - Marocco 17
PH - Filippine 16
VE - Venezuela 16
CL - Cile 15
NZ - Nuova Zelanda 13
EC - Ecuador 12
MY - Malesia 11
RO - Romania 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
AT - Austria 9
IE - Irlanda 9
TH - Thailandia 9
CR - Costa Rica 8
PT - Portogallo 8
EG - Egitto 7
JM - Giamaica 7
KE - Kenya 7
BO - Bolivia 6
JO - Giordania 6
KR - Corea 6
NP - Nepal 6
PE - Perù 6
EE - Estonia 5
IL - Israele 5
TN - Tunisia 5
AZ - Azerbaigian 4
KZ - Kazakistan 4
LB - Libano 4
QA - Qatar 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
NG - Nigeria 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
AO - Angola 2
ET - Etiopia 2
GD - Grenada 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
SN - Senegal 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
GR - Grecia 1
Totale 15.871
Città #
Ashburn 920
Singapore 902
Warsaw 764
Fairfield 605
San Jose 529
Woodbridge 517
Houston 364
Ann Arbor 360
Beijing 357
Chandler 356
Santa Clara 330
Hong Kong 293
Jacksonville 289
Seattle 233
Wilmington 220
Council Bluffs 203
Cambridge 180
Los Angeles 164
New York 160
Dallas 148
Ho Chi Minh City 121
Milan 106
Munich 106
Hanoi 103
Izmir 98
Nanjing 91
Tokyo 91
Ferrara 86
Princeton 74
Boardman 65
Lauterbourg 62
Shanghai 60
São Paulo 59
Rome 57
San Diego 54
Orem 53
Mexico City 49
Toronto 47
Brescia 46
Dong Ket 44
Bremen 43
Phoenix 43
Buffalo 41
London 41
Montreal 41
Helsinki 40
Brussels 39
Chicago 39
Jakarta 39
Brooklyn 35
Johannesburg 33
Addison 31
Turku 31
Chennai 29
Denver 29
Hefei 29
Stockholm 29
Tianjin 29
The Dalles 28
Atlanta 25
Sydney 25
Frankfurt am Main 24
Poplar 23
Shenyang 22
Nanchang 21
Bologna 20
Boston 20
Changsha 20
Da Nang 19
Jinan 19
Moscow 18
Hebei 17
Naples 17
Charlotte 16
Brno 15
Dearborn 15
Haiphong 15
Jiaxing 15
Manchester 13
Mumbai 13
Nuremberg 13
San Francisco 13
Auburn Hills 12
Florence 12
Norwalk 12
Perth 12
Rio de Janeiro 12
Amsterdam 11
Ankara 11
Brasília 11
Columbus 11
Falls Church 11
Miami 11
Querétaro 11
Wan Chai 11
Zhengzhou 11
Baghdad 10
Biên Hòa 10
Curitiba 10
Hamilton 10
Totale 10.652
Nome #
Duchenne muscular dystrophy: From diagnosis to therapy 583
Meccanismi del danno neuronale indotto dalla tossina mitocondriale sodio azide in colture primarie di corteccia di ratto. Effetti sulle Protein Kinasi C. 510
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 485
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 413
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 389
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease 328
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 324
Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype 290
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures 286
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 279
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 278
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 272
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature 271
Exon skipping-mediated dystrophin reading frame restoration for small mutations 260
Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report 259
Spatial RNA-mapping reveals the unique patterns of expression and localisation of dystrophin isoforms in the human adult normal brain to improve understanding of brain involvement in muscular dystrophy 254
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 252
Sodium Azide Induced Neuronal Damage In Vitro: Evidence for Non-Apoptotic Cell Death 247
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 240
Sodium azide: a useful tool for in vitro studying neurodegenerative diseases. 238
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 231
Biodistribution Studies of Polymeric Nanoparticles for Drug Delivery in Mice. 225
Homozygous Recessive Versican Missense Variation Is Associated With Early Teeth Loss in a Pakistani Family 222
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 216
Differential activation of protein kinase C isoforms following chemical ischemia in rat cerebral cortex slices 213
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 213
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 205
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 204
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 199
Physical and transcriptional characterization of human urinary stem cell populations 198
MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping 196
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 195
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 195
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 191
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 190
RNAseq in urine-derived stem cells identified the expression of 308 neuromuscular gene transcripts [NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY: P.384] 189
Protective effect of a peptide derived from the endogenous PKC inhibitor PKI55 on the neurosecretory function in ischemic brain slices 186
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 185
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 185
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 184
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 184
Oligomeric formylpeptide activity on human neutrophils 181
Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for duchenne muscular dystrophy. 181
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 179
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 177
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 175
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 175
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 174
null 172
Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy 172
Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of DUX4 170
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 170
Protein kinase C isoforms changes induced by chemical ischemia-reperfusion in rat cerebral cortex slices 169
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 165
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 165
mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies 163
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 159
Nanodiagnostics and nanodelivery applications in genetic alterations 158
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 154
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 149
Nanoparticles to deliver antisense oligonucleotides aimed at exon skipping therapies 145
Effects of chemical ischemia on cerebral cortex slices: focus on mitogen-activated protein kinase cascade. 130
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 127
Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases 127
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 121
New-pyrazolyl-ureas as potent human neutrophil chemotaxis inhibitors 120
Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation 120
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 119
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 116
null 113
Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. 109
new pyrazolyl ureas as potent human neutrophil chemotaxis inhibitors 100
null 96
null 94
null 92
null 92
null 90
null 87
Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils 86
null 80
Totale 16.036
Categoria #
all - tutte 65.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 809
Totale 66.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022708 0 0 58 27 28 26 62 45 33 53 124 252
2022/2023853 79 80 25 112 165 110 48 58 80 15 53 28
2023/2024582 44 45 40 16 27 104 31 52 22 18 13 170
2024/20252.198 47 36 161 115 263 227 130 108 350 258 264 239
2025/20265.905 624 267 496 829 970 370 649 270 427 571 318 114
2026/2027714 197 286 231 0 0 0 0 0 0 0 0 0
Totale 16.036